In the spring of 1945, Dorothy Hodgkin sat in her cramped Oxford laboratory, her fingers swollen by arthritis, carefully aligning a tiny crystal of penicillin in front of an X-ray beam. For months she had analysed the diffraction patterns that appeared on photographic plates – a bewildering array of spots and streaks that held the secret to the antibiotic's structure. The cluttered bench overflowed with notebooks and glassware, but her focus was absolute. As she studied the latest image, a pattern began to emerge, like a ghostly blueprint. The molecule was not a simple chain, as many had assumed, but a ring-like structure containing a beta-lactam core, a configuration no one had predicted.

This moment of insight was not just a personal triumph; it would unlock the door to mass-producing the drug that would save millions of lives from infection. Dorothy Crowfoot was born in Cairo in 1910, where her father worked for the Egyptian government. Her mother, an amateur botanist, nurtured her curiosity about the natural world, often taking her on desert walks to collect plants and insects. When Dorothy was a child, she contracted a severe illness that left her with permanent damage to her hands, but she never let this limit her ambitions.

At age ten, she received a chemistry set and began experimenting with crystals, fascinated by their geometric shapes. Later, at Somerville College, Oxford, she excelled in chemistry, graduating with first-class honours. She was one of the few women in her field and often felt the weight of expectations. Her early work under John Desmond Bernal taught her the basics of X-ray crystallography, the technique that would become her life's work. After Oxford, she joined the University of Cambridge to pursue a PhD, but soon returned to Oxford as a research fellow.

This moment of insight was not just a personal triumph; it would unlock the door to mass-producing the drug that would save millions of lives from infection.

There she began her pioneering studies of complex organic molecules. The lab was poorly funded, with outdated equipment and limited space. Yet Hodgkin thrived, developing new methods to interpret the dense patterns of X-ray diffraction. Her determination was fuelled by a deep curiosity about the hidden architecture of life. She spent long hours hunched over microscopes and photographic plates, often ignoring her own physical pain. Her first major success came in 1945 with the penicillin structure, a breakthrough that proved her technique could tackle molecules of enormous biological importance. The scientific community took notice, and she was appointed to a university lectureship.

The greatest challenge of Hodgkin's life arrived not from her work but from her body. At age 28, she was diagnosed with severe rheumatoid arthritis, a condition that would progressively deform her joints and cause relentless pain. Simple tasks like holding a pencil or adjusting an X-ray crystal became agony. Doctors advised her to reduce her workload, but she refused. Instead, she designed custom tools – padded grips for tweezers, ergonomic chairs – and trained her colleagues to assist with delicate manipulations. She also developed a system of taking notes by dictation.

Despite the physical toll, she continued to produce some of the most detailed crystallographic maps of her era, proving that perseverance could overcome even the most debilitating obstacles. The turning point in Hodgkin's career came when she turned her attention to vitamin B12, a molecule far more complex than penicillin. The structure was so intricate that many doubted it could ever be solved. Hodgkin spent the better part of a decade on the problem, using the new technique of computational crystallography to process the data. In 1955, she succeeded: the three-dimensional structure of vitamin B12 was revealed, confirming its cobalt-containing core and the arrangement of its many rings.

This discovery was a milestone in chemistry, demonstrating that large biomolecules could be mapped with precision. It also earned her the Nobel Prize in Chemistry in 1964, only the third woman ever to receive that honour. Hodgkin's resilience extended beyond her own research. She became a mentor to a generation of scientists, especially women, and used her Nobel platform to advocate for peace and international collaboration. She corresponded with scientists behind the Iron Curtain, believing that knowledge should transcend political boundaries. Her own health continued to deteriorate, but she never retired completely.

In her later years, she turned to her most challenging project: insulin. For nearly 35 years, she and her team chipped away at the structure of this crucial hormone. Finally, in 1969, at the age of 59, she announced the complete three-dimensional arrangement of insulin, a triumph that opened new avenues for diabetes treatment. Dorothy Hodgkin's work fundamentally changed how scientists understand the molecules of life. Her methods paved the way for modern drug design and structural biology. One memorable concrete detail from her life: she insisted on hand-colouring her photographic maps to make them clearer for her colleagues, a painstaking process that reflected her perfectionism.

A fun fact: although her hands were so gnarled by arthritis that she could barely write, she still drew beautiful, precise diagrams of molecular structures. Her legacy is not just the Nobel Prize or the solved structures, but the example she set: that profound discovery often requires enduring personal hardship, and that the most delicate work can be done by the most determined hands.